** Shares of drug and medical device maker Johnson & Johnson JNJ.N fall 1% to $152.75
** JNJ reports medical device sales of $8.02 billion for the quarter, which came in below analysts' estimates of $8.17 billion, as per LSEG data
** Sales of J&J's medical devices have missed Wall Street estimates for the past 4 quarters
** Co also flagged a $400 million impact from tariffs, mostly related to tariffs already in place for China and Mexico that could hurt its medical device business
** "We would caution that JNJ has some of the highest China exposure (~10%) in MedTech," said JP Morgan analysts
** Overall, JNJ reported Q1 profit and revenue above analysts' expectations
** As of last close, JNJ stock up 6.7% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.